glp 1 for cardiovascular disease The effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action Experts Encourage Use of GLP-1s

The rise of GLP-1 RAs As a retinal specialist, many of your patients are already using GLP-1 RAs and many more will receive new prescriptions in the near future

Long-term considerations for the tirzepatide to retatrutide switch Switching compounds is not just about the first few months

10.1016/j.bbr.2014.07.027 64 OuZ.PanJ.TangS.DuanD.YuD.NongH.et al

Official supply shortages persisted for most of 2024, as surging demand for AOMs continued to outstrip product supply, despite limited reimbursement, which presented an opportunity quickly seized upon by U.S

Patients who are at all concerned about this should contact the Surgery via our online form giving details of their concerns and we will contact them with advice

BMJ Open 11 , e047993 (2021)